Foamix Pharmaceuticals Ltd. Marketable Securities (Non-Current)
Foamix Pharmaceuticals Ltd. had Marketable Securities (Non-Current) of $150.00 thousand as of 2018-12-31, per its 10-K filed 2020-03-12.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Long-Term Investments
us-gaap:MarketableSecuritiesNoncurrent · last filed 2020-03-12
- 2018-12-31: Marketable Securities, Noncurrent $150.00K.
- 2018-09-30: Marketable Securities, Noncurrent $793.00K.
- 2018-06-30: Marketable Securities, Noncurrent $1.57M.
- 2018-03-31: Marketable Securities, Noncurrent $5.05M.
| Period end | Marketable Securities, Noncurrent |
|---|---|
| 2018-12-31 | $150.00K 10-K · filed 2020-03-12 |
| 2018-09-30 | $793.00K 10-Q · filed 2018-11-07 |
| 2018-06-30 | $1.57M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $5.05M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $8.53M 10-K · filed 2019-02-28 |
| 2017-06-30 | $10.96M 6-K · filed 2017-08-08 |
| 2016-12-31 | $17.53M 10-K · filed 2018-03-01 |
| 2016-06-30 | $14.60M 6-K · filed 2016-08-10 |
| 2015-12-31 | $32.28M 20-F · filed 2017-02-21 |